NCT04601584 2024-03-06GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLAO GENERIUMPhase 1/2 Unknown36 enrolled
NCT04309084 2023-02-16Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaCelularity IncorporatedPhase 1 Unknown29 enrolled